Firms Ask If DDMAC Will Assess Early Promo Claims Under TPP Guidance

FDA's draft guidance directing sponsors to present proposed promotional claims in a "Target Product Profile" at the beginning of the drug development process does not address how the Division of Drug Marketing, Advertising, and Communications would be involved in the process